Skip to main content
Fig. 3 | BMC Pharmacology and Toxicology

Fig. 3

From: A retrospective study of the safety and efficacy of clopidogrel versus aspirin monotherapy one year after coronary stent implantation

Fig. 3

The hazard ratios for the primary efficacy endpoint (a composite of all-cause death, myocardial infarction, and stroke complications) in both groups are shown according to prespecified and post-hoc subgroups. DM diabetes mellitus, hyperlipemia, MI history previous infarction, DES Drug-eluting stent history, chronic kidney disease, ACS acute coronary syndrome

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us